Monoclonal antibodies have higher specificity and affinity compared to polyclonal antibodies. ProSci uses hybridoma development for mouse monoclonal antibody development, which is a more established technology compared to recombinant antibody methods.
We have over 25 years of experience developing monoclonal antibodies; working with customers worldwide across a broad range of research areas in academia and industry to take on challenging antibody needs. ProSci antibody experts allow researchers to focus on optimizing other aspects of their research.
Hybridoma (fusion) technology is a traditional method to develop mouse monoclonal antibodies. Our specially developed techniques ensure successful hybridoma development with a fusion success rate over 98%. We guarantee stable cell lines with ELISA positive clones, and careful screening throughout monoclonal antibody development.
We start our monoclonal antibody development process with BALB/c mice for hybridoma development. BALB/c is a very common species throughout the industry for monoclonal antibody development due to their large spleen to body size ratio. This yields a higher number of splenocytes at fusion which increases the likelihood of obtaining your desired antibody.
Phase
Week
Procedure
Detailed Procedure
I
13-16 Weeks
Immunization
II
2-3 Weeks
Fusion
III
4-6 Weeks
Subcloning
Antigen Purity
Protein Antigen
Peptide Antigen
We offer ELISA screening throughout the entire project and can deliver the final positive clones to you!
You can take an active role in your monoclonal antibody development to ensure the right results by screening ELISA-positive supernatants in your lab. Contact our experts to learn more about our screening options. We highly recommend screening positive wells in your lab as this will increase the chances of developing a cell line that produces monoclonal antibodies that work in your target application.
ProSci offers three packages for hybridoma development:
Three phase hybridoma development for 1 clone using client-provided antigen (recommended for protein antigens only)
hree phase hybridoma development for 3 clones using client-provided antigen
Three phase hybridoma development for 3 clones using ProSci-provided antigen
Individual Phases
Additonal Clones: If you would like more final clones than the quantity included in a package, we would be happy to assist and can provide additional clones for your project.
Final Clone Isotyping: If you would like us to isotype any additional final clones for your project, we would be happy to assist by providing this service for you.
Additional ELISA Screening: If you need a highly specific monoclonal antibody, we can assist with narrowing down the specificity by screening against multiple samples by ELISA, either positive or negative. Contact our custom antibody experts to discuss your project today.
Because of the nature of developing antibodies from immunization to final clones, we implement project milestones consisting of clear, actionable go/no-go decision points during the development process. Our experts review the antibody development progress at each milestone to assure antibody success. In addition, if you use a protein, or ProSci selected the peptide immunogen, we guarantee an immune response in Phase I and ELISA positive clones to the immunogen at the end of the project.
Once monoclonal antibody development is complete, production can start. Our methods have a 5-25 fold increase in yields over conventional monoclonal antibody cell culture techniques and offer serum and serum-free media formulations as well as antibody purification.
Whether your research involves therapeutics, diagnostics, or any other area of study, ProSci offers an extensive collection of custom monoclonal antibody services for your consideration.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |